The focus of this deployment group is to pave the way for a new and more favourable funding landscape for the European bio-based sector by 2030. The group’s vision is to mobilise capital, create better funding opportunities and offer solutions ready for the market and industrial production. In order to do that, different investment sources available in Europe for projects with higher technology readiness level (TRL) and commercial scale deployment should be grouped and efficiently mobilised.
Representatives of financial institutions and investors met in Brussels on 22 April 2026 with the aim to set the mandate, tasks and operating model of the deployment group and exchange on its work plan for the 2026-2029 period. More details